Prostate Cancer - Results from #25540

Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden - Abstract June 25, 2012

External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort - Abstract June 25, 2012

Cohort profile: The National Prostate Cancer Register of Sweden and Prostate Cancer Data Base Sweden 2.0 - Abstract June 25, 2012

Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy - Abstract June 25, 2012

Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy - Abstract June 25, 2012

The role of a well-trained team on the early learning curve of robot-assisted laparoscopic procedures: The example of radical prostatectomy - Abstract June 22, 2012

Psychological research and the prostate-cancer screening controversy - Abstract June 22, 2012

Next-generation prostate cancer biobanking: Toward a processing protocol amenable for the International Cancer Genome Consortium - Abstract June 22, 2012

Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: A survey by the Brazilian Society of Urology - Abstract June 22, 2012

Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: Correlation with prostate epithelial cells isolated from seminal fluid - Abstract June 22, 2012

A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer - Abstract June 22, 2012

A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer - Abstract June 22, 2012

Diagnostics of radical prostatectomy specimens : Results of the 2009 consensus conference of the International Society of Urological Pathology - Abstract June 22, 2012

Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer - Abstract June 22, 2012

Advanced prostate cancer as a cause of oncogenic osteomalacia: An underdiagnosed condition - Abstract June 22, 2012

ASCO 2012 - An interview with Charles J. Ryan, MD: Presentation of the New Paradigms for Hormone Therapy in Prostate Cancer, clinical symposium at the ASCO 2012 Annual Meeting June 22, 2012

Intervening to improve psychological outcomes for men with prostate cancer - Abstract June 22, 2012

The interactions between insulin and androgens in progression to castrate-resistant prostate cancer - Abstract June 21, 2012

Prostate cancer mortality and birth or adult residence in the southern United States - Abstract June 21, 2012

Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: A preplanned safety report of the SPCG-13 trial - Abstract June 21, 2012

Page 1278 of 1436